270 results on '"Jelinek, D."'
Search Results
2. Effects of Interferon Alpha on Myeloma Cells: Mechanisms of Differential Responsiveness
3. Sequence, Expression and Function of an mRNA Encoding a Soluble Form of the Human Interleukin-6 Receptor (sIL-6R)
4. Molecular and Biological Role of CD40 in Multiple Myeloma
5. Genetic characterization of SF3B1 mutations in single chronic lymphocytic leukemia cells
6. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls
7. Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation
8. Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse
9. Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population
10. Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX
11. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
12. Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma
13. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation
14. ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype
15. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance
16. Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma
17. CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL
18. ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia
19. Identification of pan B-cell neoplasm markers using a combination of cDNA PCR subtraction and microarray analysis: 720
20. Identification of genes associated with multiple myeloma and monoclonal gammopathy of undetermined significance using the myeloma microarray: 241
21. Erratum: VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance
22. Reply to ‘CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance’ by Zucchetto et al.
23. No Improvement In Long-Term Overall Survival After The Introduction Of Chemo(Immuno)Therapy For Chronic Lymphocytic Leukemia Patients Belonging To Stereotyped Subset #2
24. HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA : UNIQUENESS VERSUS EQUIVALENCE
25. Higher-order immunoglobulin sequence relations for major subsets of chronic lymphocytic leukemia: uniqueness versus equivalence
26. Immunoglobulin Heavy Variable Genes and Alleles : New Entities, New Names and Implications for Research and Prognostication in CLL
27. Not All IGHV3-21 CLL Are Equal : Subset #2 Displays a Distinctive Clinicobiological Profile with Remarkable Similarities to Subset #169, its Close Immunogenetic Relative
28. Connected authentic learning: Reflection and intentional learning
29. TALEN-mediated genetic tailoring as a tool to analyze the function of acquired mutations in multiple myeloma cells
30. Identification of pan B-cell neoplasm markers using a combination of cDNA subtraction and microarrayanalysis
31. Identification of genes associated with multiple myeloma and monoclonal gammopathy of undetermined significance using the myeloma microarray
32. Student reflection and learning through peer reviews
33. Designing, developing and evaluating authentic online educational assessment
34. Peer reviews: What can we learn from our students?
35. Identification of pan B-cell neoplasm markers using a combination of cDNA PCR subtraction and microarray analysis
36. Perceptions and reflections: Using Skype chat to build a community of learners
37. Chronic lymphocytic leukemia in young (<= 55 years) patients: a comprehensive analysis of prognostic factors and outcomes
38. Molecular analysis of immunoglobulin genes reveals frequent clonal relatedness in double monoclonal gammopathies
39. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls
40. 5.11 Lenalidomide Consolidation Seems to Prolong Time to Retreatment After First-Line Chemoimmunotherapy for Patients with Previously Untreated Chronic Lymphocytic Leukemia
41. 5.12 Ofatumumab-Based Chemoimmunotherapy for Patients With Previously Untreated Chronic Lymphocytic Leukemia
42. Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population
43. Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance
44. Phase II trial of daily, oral green tea extract in patients with asymptomatic, Rai stage 0-II chronic lymphocytic leukemia (CLL).
45. Thermal hydraulic analyzer
46. Evaluation of contaminant plume removal with global optimization
47. Pressure drop and pumping power for fluid flow through round tubes
48. Optimization of fluid line sizes with pumping power penalty IBM-360 computer program
49. Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma
50. 50 MOTEXAFIN GADOLINIUM, A REDOX MEDIATOR, INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS AND IS ADDITIVE OR SYNERGISTIC WITH FLUDARABINE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.